Category

Daily Briefs

Daily Brief Australia: PointsBet Holdings , Strategic Minerals PLC and more

By | Australia, Daily Briefs

In today’s briefing:

  • PointsBet (PBH AU): Mixi Attempts to Call Betr’s Bluff with a Final Offer
  • PointsBet (PBH AU): Mixi Bumps, Again, And Declares Terms Final
  • Strategic Minerals PLC – Hybridan Small Cap Feast: 14/08/2025


PointsBet (PBH AU): Mixi Attempts to Call Betr’s Bluff with a Final Offer

By Arun George

  • Mixi Inc (2121 JP) disclosed its final PointsBet Holdings (PBH AU) offer. The base unconditional offer remains A$1.25 but will be increased to A$1.30 if it acquires a 90% stake. 
  • Mixi’s final offer is designed to put maximum pressure on BETR Entertainment (BBT AU) to fold. Mixi would not satisfy the 90% threshold unless Betr accepts its offer.
  • Betr has three options: to improve its offer, accept Mixi’s offer, or maintain terms. The last option, which results in a significant stake in a competitor, makes strategic sense.

PointsBet (PBH AU): Mixi Bumps, Again, And Declares Terms Final

By David Blennerhassett

  • Mixi Inc (2121 JP) has bumped its Offer to A$1.30/share, up from A$1.25/share; and declared terms final. Mixi currently holds 37.12% of shares out. 
  • Separately, PointsBet Holdings (PBH AU) released its Target Statement as it relates betr Entertainment (BBT AU)‘s all-scrip Offer, with a definitive “Reject”.
  • Mixi’s Offer is open to the 29th August – and will not be extended. Time for betr to fold its tent.

Strategic Minerals PLC – Hybridan Small Cap Feast: 14/08/2025

By Hybridan

  • Our daily digest of news from UK Small Caps Feast will take a well earned break for the weeks of 18th and 25th August.
  • Wishing everyone a lovely summer holiday period.
  • 14th August 2025 @HybridanLLP * A corporate client of Hybridan LLP.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: iFAST, Soilbuild Construction, SGX Rubber Future TSR20 and more

By | Daily Briefs, Singapore

In today’s briefing:

  • iFAST Corporation Limited: Breaking Out
  • SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24
  • Deals, Recycling, Research And AI Power Thailand’s Rubber Shift


iFAST Corporation Limited: Breaking Out

By GEMS Research – Aletheia Capital

  • IFAST SP has risen 28% since our initiation and has seen net institutional outflows of S$50m in the first week of the month.
  • We see further upside of 12%, as the value in terms of P/AUM is not reflected in the price.
  • Recent private transactions such as the Chocolate Finance Series A+ deal round indicate that iFAST is cheap relative to its assets. There is a strong chance of a buy back in 2026.

SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24

By SAC Capital

  • Soilbuild delivered a stellar financial performance in 1HFY25.
  • The Group’s 1HFY25 net profit surged 282.9% YoY to S$28.3 million, exceeding FY24 full year net profit of $26.6 million.
  • 1HFY25 revenue increased 77.3% YoY to S$272.8 million, while gross profit jumped 193.5% YoY to S$43.6 million, reflecting strong execution and margin improvements across both construction and precast operations.

Deals, Recycling, Research And AI Power Thailand’s Rubber Shift

By Vinod Nedumudy

  • Bridgestone reshapes carbon black strategy with Tokai Carbon  
  • Hanwa invests in Thai tyre pyrolysis venture  
  • Sri Trang bets on AI and workforce upskilling

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: SGX Rubber Future TSR20 and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Deals, Recycling, Research And AI Power Thailand’s Rubber Shift


Deals, Recycling, Research And AI Power Thailand’s Rubber Shift

By Vinod Nedumudy

  • Bridgestone reshapes carbon black strategy with Tokai Carbon  
  • Hanwa invests in Thai tyre pyrolysis venture  
  • Sri Trang bets on AI and workforce upskilling

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Samsung Life Insurance, Myungin Pharmaceutical and more

By | Daily Briefs, South Korea

In today’s briefing:

  • True Aspect (Trade-Wise) Of the Samsung Life Accounting Issue: Today’s Biggest Market Narrative
  • Myungin Pharmaceutical IPO Preview


True Aspect (Trade-Wise) Of the Samsung Life Accounting Issue: Today’s Biggest Market Narrative

By Sanghyun Park

  • Both accounting issues are complex, but intense regulator scrutiny fuels the Samsung Life Act case, sparking governance reshuffle bets and driving today’s Samsung Life stock pop.
  • Accounting rechecks could spark divestment fears or governance-driven rerating, creating a classic headline-driven, bidirectional trading setup.
  • Near-Term, this is a headline-driven momentum setup: Samsung Life longs/shorts, ready to pivot, with relative-value plays vs financial peers or Samsung’s governance-linked names.

Myungin Pharmaceutical IPO Preview

By Douglas Kim

  • Myungin Pharmaceutical is getting ready to complete its IPO in KOSPI in September. The IPO price range is from 45,000 won to 58,000 won. 
  • The total offering amount ranges from 153 billion won ($111 million) to 197 billion won ($143 million). The book building for the institutional investors lasts from 9 to 15 September. 
  • Using EBITDA of 104.5 billion won and EV/EBITDA of 7.9x and IPO discount ranges of 32.2% to 47.4%, this resulted in IPO price range of 45,000 won to 58,000 won. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Fractal Analytics Ltd, Lumax Auto Technologies, Nazara Technologies, Mangal Electrical Industries and more

By | Daily Briefs, India

In today’s briefing:

  • Fractal Analytics Pre-IPO Tearsheet
  • The Beat Ideas: Lumax Auto Technologies – Accelerating Ahead with the 20.20.20.20 Strategy
  • Nazara Technologies in Turbulence: Temporary Setback or Lasting Damage?
  • Mangal Electrical IPO: A Strong Force in Transformer and Power Solutions?


Fractal Analytics Pre-IPO Tearsheet

By Akshat Shah

  • Fractal Analytics Ltd (2453623D IN) is looking to raise about US$560m in its upcoming India IPO. The deal will be run by Axis, GS, MS and Kotak.
  • Fractal Analytics Limited is an enterprise artificial intelligence (AI) company which supports large global enterprises with data-driven insights and assists them in their decision making through its end-to-end AI solutions.
  • According to the Everest Report, FAL was India’s leading pure-play enterprise data, analytics and AI company, recognized globally, with capabilities across the data, analytics and AI (DAAI) value chain.

The Beat Ideas: Lumax Auto Technologies – Accelerating Ahead with the 20.20.20.20 Strategy

By Sudarshan Bhandari

  • Lumax’s strong product portfolio, global partnerships, and 80% market share in key segments position it as a dominant player in India’s automotive component industry.
  • Lumax’s strategic acquisitions, including IAC India and GreenFuel Mobility, and the “NorthStar Strategy” aim to drive revenue growth, operating margins, and leadership in clean mobility solutions.
  • Lumax’s SHIFT project enable technological integration, enhancing product offerings and content per vehicle, positioning LATL for long-term growth in the automotive market.

Nazara Technologies in Turbulence: Temporary Setback or Lasting Damage?

By Sudarshan Bhandari

  • The Lok Sabha passed the Online Gaming Bill, 2025, banning all RMG platforms and putting Nazara’s PokerBaazi investment at significant risk.
  • While Nazara has no direct RMG exposure, its INR 805 crore PokerBaazi bet could turn worthless, raising concerns over capital allocation and valuation pressure. 
  • Core businesses remain strong, but regulatory uncertainty warrants caution. Near-term downside risks persist; long-term clarity hinges on execution and policy direction. 

Mangal Electrical IPO: A Strong Force in Transformer and Power Solutions?

By Nimish Maheshwari

  • MEIL is well-positioned for long-term growth due to its expertise in transformer components and EPC services, strong market presence, with a solid focus on India’s energy infrastructure development.
  • MEIL benefits from both backward and forward integration, enhancing operational efficiency and reducing raw material dependency. Its diversified customer base spans multiple sectors, reducing exposure to sector-specific risks.
  • MEIL’s has shown steady growth, driven by its core and EPC businesses. Despite risks like raw material volatility, the company is well-placed to capitalize on India’s growing power infrastructure demand.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Mosaic Co/The, Intel Corp, Salesforce.Com Inc, Halozyme Therapeutics, Hamilton Lane, Snap , Newton Golf Company, Skyworks Solutions, Schlumberger Ltd, Shift4 Payments and more

By | Daily Briefs, United States

In today’s briefing:

  • The Mosaic Company: Riding The Fertilizer Boom With Pricing Power & Market Edge!
  • Masa’s AI Double Down: Masterstroke or Misstep?
  • CRM US – Salesforce Bets On Agentic Automation: What The Regrello Acquisition Could Unlock!
  • Halozyme Therapeutics: ENHANZE Platform Expansion & Critical Factors That Will Define Its Success in 2025 and Beyond!
  • Hamilton Lane: Initiation of Coverage- Reinventing Its Distribution Strategy — How Will Its Innovation Shape Private Market Leadership?
  • Snap Inc Is Focusing On SMBs — Could Smarter Ads Unlock Revenue Growth?
  • NWTG: Newton Golf reports strong 2nd quarter 2025 revenue growth. The Newton Shaft lineup continues to be the primary growth driver.
  • Skyworks Solutions: AI-Driven Growth in Smartphone Markets Benefiting Through Increased Sales Volume & Higher Content Per Device!
  • The Equity Dispatch #48: SLB: Papering Over the Problems Is Making Them Worse
  • Shift4 Payments: Can They Power Future Growth With Stablecoin & Agentic Commerce Innovation?


The Mosaic Company: Riding The Fertilizer Boom With Pricing Power & Market Edge!

By Baptista Research

  • The Mosaic Company recently shared its financial results for the second quarter of 2025, showcasing a mixed performance largely characterized by operational challenges but an optimistic future outlook.
  • The company’s efforts to enhance operating efficiencies and asset reliability are starting to bear fruit, though certain operational interruptions have impacted short-term outcomes, particularly in the phosphates segment.
  • For the quarter, The Mosaic Company reported net income of $411 million, a significant turnaround from last year’s net loss of $162 million.

Masa’s AI Double Down: Masterstroke or Misstep?

By Raghav Vashisht

  • SoftBank widens its AI bet with a $2B stake in Intel, suffers a 12% dip over two consecutive days.
  • Nvidia’s dominance has hyperscalers wary of lock-in. With Amazon and Microsoft building their chips, SoftBank’s move lands right as the market searches for alternatives.
  • Can Son replicate Intel’s historic design-fab alignment in AI, or would execution risk outweigh his ecosystem-diversification logic?

CRM US – Salesforce Bets On Agentic Automation: What The Regrello Acquisition Could Unlock!

By Baptista Research

  • Salesforce is charging deeper into the AI frontier.
  • On August 18, 2025, the CRM titan announced a definitive agreement to acquire Regrello, an AI-native startup that specializes in transforming fragmented business processes into orchestrated, automated workflows.
  • The deal, expected to close in Salesforce’s fiscal Q3 2026, underscores the company’s commitment to building out its “agentic enterprise” vision—where human workers and AI agents collaborate in real time.

Halozyme Therapeutics: ENHANZE Platform Expansion & Critical Factors That Will Define Its Success in 2025 and Beyond!

By Baptista Research

  • Halozyme Therapeutics, Inc. reported its second quarter 2025 financial results, marking a period of robust growth.
  • The company announced a 41% increase in total revenue, reaching $326 million, driven primarily by strong royalty revenue, which saw a 65% year-over-year rise to $206 million.
  • The growth is attributed to the continued performance of blockbuster subcutaneous therapies such as DARZALEX, Phesgo, and VYVGART Hytrulo, which are enhanced by Halozyme’s ENHANZE technology.

Hamilton Lane: Initiation of Coverage- Reinventing Its Distribution Strategy — How Will Its Innovation Shape Private Market Leadership?

By Baptista Research

  • Hamilton Lane’s first quarter of fiscal 2026 showcased a multifaceted financial performance, marked by both growth and areas of concern.
  • The company’s total asset footprint has seen a 5% year-on-year increase, reaching $986 billion, indicating robust growth across both specialized funds and customized separate accounts.
  • These asset categories contributed significantly to the near $11 billion increase in Assets Under Management (AUM), now totaling $141 billion, reflecting a substantial 9% growth year-over-year.

Snap Inc Is Focusing On SMBs — Could Smarter Ads Unlock Revenue Growth?

By Baptista Research

  • Snap Inc.’s financial results for the second quarter of 2025 offer a mixed bag of achievements and challenges.
  • Positively, the company’s engagement metrics continue to demonstrate strong growth, with Monthly Active Users (MAUs) reaching 932 million, an increase of 7% year-over-year.
  • This growth signifies Snap’s appeal, particularly among Gen Z and Millennial demographics.

NWTG: Newton Golf reports strong 2nd quarter 2025 revenue growth. The Newton Shaft lineup continues to be the primary growth driver.

By Zacks Small Cap Research

  • Newton Golf (NASDAQ: NWTG) is an innovative, technology driven golf company with a growing portfolio of golf products, including putters, golf shafts, golf grips, and other golf-related accessories.
  • The company went public in August 2023 raising $11.6 million in net proceeds.
  • The company announced its entry into the golf shaft market in November 2023.

Skyworks Solutions: AI-Driven Growth in Smartphone Markets Benefiting Through Increased Sales Volume & Higher Content Per Device!

By Baptista Research

  • Skyworks Solutions, Inc. reported its third quarter fiscal 2025 results, delivering above-expectation performance in key financial metrics, including revenue, earnings per share (EPS), and free cash flow.
  • The company reported revenue of $965 million, which exceeded the high end of its guidance, owing to robust performance in both its Mobile and Broad Markets segments.
  • The earnings per share of $1.33 and free cash flow of $253 million were also above guidance, marking a solid quarter for the company.

The Equity Dispatch #48: SLB: Papering Over the Problems Is Making Them Worse

By J Capital Research

  • Since our last newsletter addressing concerns about Schlumberger NV (SLB) dated in October of 2023, the company’s share price has fallen by 41% on an absolute basis, while the S&P 500 is up 50.4% over the same period.
  • For a company with a market capitalization of $49.2 bln, this is significant.
  • Our primary concerns were that SLB had potential write offs related to outstanding receivables from its Mexican PEMEX customer as well as continued exposure to Russia.

Shift4 Payments: Can They Power Future Growth With Stablecoin & Agentic Commerce Innovation?

By Baptista Research

  • Shift4 Payments recently reported its financial results for the second quarter of 2025, reflecting both positive developments and some potential challenges.
  • The company’s strategic initiatives, international expansion, and recent acquisitions underscore its growth trajectory while simultaneously posing integration and execution risks.
  • In terms of financial performance, Shift4 Payments achieved 25% year-over-year growth in payment volumes, surpassing $50 billion for the first time.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: First Pacific Co, Wuxi Biologics, Jiaxin International Resources Investment Limited, Kuaishou Technology, EpimAb Biotherapeutics, Iron Ore, Shanghai Forest Cabin Biological-Tech, Jiangsu Hengrui Pharmaceuticals, Seazen Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • First Pacific (142 HK) Is Fully Valued Here
  • Wuxi Biologics (2269 HK): Expanded Offering and Capacity Drive 1H25 Result; Accelerated Growth Ahead
  • Jiaxin International Resources Investment IPO – No Track Record, Government Supported
  • KS / Kuaishou (1024 HK): 2Q25, Op Profit Up by 35% YoY, 91% Upside
  • EpimAb (岸迈生物) Pre-IPO: Differentiated Bispecific Products
  • [IO Technicals 2025/34] Iron Ore Braces for Bullish Shift After Six-Day Slide
  • Shanghai Forest Cabin Biological Tech. Pre-IPO: A Play on Aging Population But With A Few Wrinkles
  • Jiangsu Hengrui (1276 HK): Robust 1H25; Innovative Drugs Key; Out-Licensing Affirm Pipeline Strength
  • Lucror Analytics – Morning Views Asia


First Pacific (142 HK) Is Fully Valued Here

By David Blennerhassett


Wuxi Biologics (2269 HK): Expanded Offering and Capacity Drive 1H25 Result; Accelerated Growth Ahead

By Tina Banerjee

  • Wuxi Biologics (2269 HK) logged solid performance in 1H25, with revenue growing 16% YoY to RMB10B and net profit increasing 55% YoY to RMB3B. Revenue from continuing operations grew 20%.
  • Total backlog reached $20B as of June 30, 2025, including $11B service backlog, while the total backlog within three years stood at $4B, enhancing near-term revenue visibility.
  • The company raised 2025 revenue growth target to 14–16% YoY from 12–15% YoY earlier. This indicates 2H25 revenue to be RMB11,524M, up 14% YoY and 16% HoH.

Jiaxin International Resources Investment IPO – No Track Record, Government Supported

By Sumeet Singh

  • Jiaxin International Resources Investment Limited (JIRI) is looking to raise around US$153m in its upcoming Hong Kong IPO.
  • Jiaxin International owns exclusive rights to a globally significant tungsten asset, supported by Jiangxi Copper. Commercial production began in April 2025, with full ramp-up expected by 2027.
  • We have looked at the company’s background in our earlier note, in this note we talk about the deal pricing.

KS / Kuaishou (1024 HK): 2Q25, Op Profit Up by 35% YoY, 91% Upside

By Ming Lu

  • The growth rate of GMV (Gross Merchandise Value) rose to 18% YoY in 2Q25 from 15% YoY in 1Q25.
  • The operating margin improved to 13% in 2Q25 from 11% in 2Q24 so that operating profit increased by 35% YoY in 2Q25.
  • We conclude an stock upside of 91% for the next twelve months. Buy.

EpimAb (岸迈生物) Pre-IPO: Differentiated Bispecific Products

By Ke Yan, CFA, FRM

  • EpimAb, a China-based clinical stage biotech company, is looking to raise at least USD 100 million via a Hong Kong listing. CITIC Securities and CMBI are the joint sponsors.
  • In this note, we look at the company’s product pipeline, its pre-IPO investors, and management.
  • Our initial view is that the company does provide a line-up of differentiated products though still in early stage of clinical development.

[IO Technicals 2025/34] Iron Ore Braces for Bullish Shift After Six-Day Slide

By Umang Agrawal

  • Iron ore drops on Tangshan curbs, but stable hot metal output underpins near-term price support. 
  • Managed money participants remain net long in iron ore, but softer buying momentum signalled profit-taking.  
  • Mean reversion and bullish MA crossover signal upside potential for the 62%/65% spread. 

Shanghai Forest Cabin Biological Tech. Pre-IPO: A Play on Aging Population But With A Few Wrinkles

By Hong Jie Seow

  • Shanghai Forest Cabin Biological-Tech (SFCBT HK)  is looking to raise at least US$100m in its upcoming Hong Kong IPO.
  • SFC is the leader among China’s premium domestic skincare brands. In 2024, SFC was ranked first among all premium domestic skincare brands in China by retail sales.
  • In this note, we look at the company’s past performance.

Jiangsu Hengrui (1276 HK): Robust 1H25; Innovative Drugs Key; Out-Licensing Affirm Pipeline Strength

By Tina Banerjee

  • In 1H25, Jiangsu Hengrui reported 16% YoY increase in revenue to RMB 15.8B primarily attributable to the growth of innovative drugs sales along with increase in licensing revenue.
  • R&D expenses surged 6% to RMB 3.2B due to ongoing clinical trials. Net profit increased 30% YoY to RMB 4.5B resulting in net margin expanding 310bps to 28.3% in 1H25.
  • In 1H25, the company obtained marketing approvals for six Class 1 innovative drugs, including trastuzumab rezetecan injection (as second line of treatment for NSCLC with HER2 mutations).

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Seazen Group, Japfa Comfeed
  • UST yields declined 1-2 bps yesterday, amid limited macro catalysts and following good demand for an auction of 20Y notes. The yield on the 2Y UST was unchanged at 3.75%, while the yield on the 10Y UST fell 2 bps to 4.29%.
  • Equities retreated for a second day, driven by broad decreases in tech heavyweights amid concerns over AI profitability. The S&P 500 slid 0.2% to 6,396, while the Nasdaq was down 0.7% at 21,173.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Kawasaki Heavy Industries, Ryohin Keikaku, Shibaura Electronics, Freee KK, Dentsu Inc, JFE Holdings, TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Japan

In today’s briefing:

  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)
  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Ryohin Keikaku (7453 JP)
  • Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer
  • 2025 High Conviction – Freee: 4Q Setback Is Only Temporary
  • Dentsu Group — Japan performs well, international tougher
  • JFE Holdings (5411 JP) – Soft Q1 Priced In; Compelling Upside from Lowest EV/Ton in Peers
  • Isn’t the Market Impatient for the Companies to Implement Management Reforms?


[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • These changes were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. Watch the direct peers.

[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Ryohin Keikaku (7453 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • They were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. This sets up a possible trade before or into the event.

Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer

By Arun George

  • In response to Minebea Mitsumi (6479 JP) matching its Shibaura Electronics (6957 JP) offer on 14 August, Yageo Corporation (2327 TT) increased its offer by 7.0% from JPY6,200 to JPY6,635.  
  • To remain in the game, Yageo had to bump. The latest bump underscores Yageo’s confidence in securing regulatory approvals. 
  • The Minebea CEO suggested that its JPY6,200 offer would be the final one. If Yageo secures regulatory approval (likely), Minebea will walk rather than match Yageo’s latest offer. 

2025 High Conviction – Freee: 4Q Setback Is Only Temporary

By Shifara Samsudeen, FCMA, CGMA

  • Freee KK (4478 JP)  reported 4Q and full-year FY06/2025 results last week which disappointed the market leading to a sell-off.
  • After reporting 3-consecutive quarters of Adj. OP, profitability dipped in 4Q due to higher advertising and D&A costs. However, freee expects to return to profits in the current fiscal year. 
  • Following 4Q results, premium over Money Forward has disappeared and Freee is currently trading at a huge discount to MF which seems unwarranted

Dentsu Group — Japan performs well, international tougher

By Edison Investment Research

Dentsu’s Q225 performance was a little below management expectations, with conditions remaining challenging outside Japan. Group operating margins were controlled for H125 at 12.0%. With a further goodwill write-down of ¥86.0bn, Dentsu reported a statutory loss for H125 and is not now paying an interim dividend. A decision on the full year will be made later, and our model assumes dividends resume for FY26. Our FY25 forecasts have been realigned to match revised guidance, with a slightly more cautious stance on growth for FY26. Management’s target for operating margins of 16–17% by FY27 remains in place, predicated on the targeted cost reductions in the mid-term management plan.


JFE Holdings (5411 JP) – Soft Q1 Priced In; Compelling Upside from Lowest EV/Ton in Peers

By Rahul Jain

  • Q1 FY2025 was weak with Steel swinging to losses (–¥2,300/t) on spreads, FX, and inventory drag, leaving recovery hinging on H2.
  • We retain our FY25–28 earnings estimates, assuming stable ~15–16% EBITDA margins and volume growth to 31.6 Mt by FY28.
  • At ~US$525/t EV/t (adj.), JFE trades at a deep discount to Nippon Steel, but upside depends on spreads stabilizing and tariff risks not worsening.

Isn’t the Market Impatient for the Companies to Implement Management Reforms?

By Aki Matsumoto

  • More companies are mentioning share buybacks, reducing cross-shareholdings, capital allocation policies, and capital costs. However, the ROE of most companies has not improved significantly.
  • “TSE’s request” is at critical juncture addressing whether it’ll lead to formal improvements such as the introduction of corporate governance code, or whether it’ll enable sustainable growth in corporate value.
  • Looking at recent market trends, investors are increasingly expecting activist investors to directly demand management reforms from companies, in anticipation that it’ll take time to realize results of internal reforms.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Kawasaki Heavy Industries, Mangal Electrical Industries, Soilbuild Construction, bpost SA, Hesai Group, Lennox International and more

By | Daily Briefs, Industrials

In today’s briefing:

  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)
  • Mangal Electrical IPO: A Strong Force in Transformer and Power Solutions?
  • SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24
  • What’s News in Amsterdam – 21 August (Aegon | a.s.r. Nederland | dsm-firmenich | Alfen | bpostgroup)
  • [Hesai Group (HSAI US, BUY, TP US$35) Review]: Rapid Cost Down Continued Driving Penetration
  • Lennox’s $550 Million HVAC Play: What The NSI Industries Acquisition Could CHANGE For The Cooling Giant!


[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • These changes were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. Watch the direct peers.

Mangal Electrical IPO: A Strong Force in Transformer and Power Solutions?

By Nimish Maheshwari

  • MEIL is well-positioned for long-term growth due to its expertise in transformer components and EPC services, strong market presence, with a solid focus on India’s energy infrastructure development.
  • MEIL benefits from both backward and forward integration, enhancing operational efficiency and reducing raw material dependency. Its diversified customer base spans multiple sectors, reducing exposure to sector-specific risks.
  • MEIL’s has shown steady growth, driven by its core and EPC businesses. Despite risks like raw material volatility, the company is well-placed to capitalize on India’s growing power infrastructure demand.

SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24

By SAC Capital

  • Soilbuild delivered a stellar financial performance in 1HFY25.
  • The Group’s 1HFY25 net profit surged 282.9% YoY to S$28.3 million, exceeding FY24 full year net profit of $26.6 million.
  • 1HFY25 revenue increased 77.3% YoY to S$272.8 million, while gross profit jumped 193.5% YoY to S$43.6 million, reflecting strong execution and margin improvements across both construction and precast operations.

What’s News in Amsterdam – 21 August (Aegon | a.s.r. Nederland | dsm-firmenich | Alfen | bpostgroup)

By The IDEA!

  • In today’s edition: • Aegon | 1H25 OCG looks a bit light; review to relocate legal domicile and head office to US • a.s.r. Nederland | post earnings call comment • dsm-firmenich | in exclusive talks with CVC on its AHN division; may keep minority stake • Alfen | reiterates FY25 guidance, however, revises FY26 ambition downward • bpostgroup | temporarily suspends individual parcel shipments to the US

[Hesai Group (HSAI US, BUY, TP US$35) Review]: Rapid Cost Down Continued Driving Penetration

By Eric Wen

  • HESAI (HSAI) reported C2Q25 top line, non-GAAP operating profit and GAAP net income in-line, 143% and 6019% vs. our estimate. 
  • ADS LiDAR shipment beat our estimate by 50%, growing 276% YoY and 108% QoQ; Robotic LiDAR grew 744% YoY and (2%) QoQ, beating our estimate by 32%; 
  • Despite the ASP erosion, gross margin grew 2.2ppt YoY and 0.9ppt QoQ to 42.5%, missing our estimate by 0.5ppt. We reiterate our TOP BUY and raise TP to US$35.

Lennox’s $550 Million HVAC Play: What The NSI Industries Acquisition Could CHANGE For The Cooling Giant!

By Baptista Research

  • Lennox International Inc.’s second quarter results provide a comprehensive view into the company’s operational dynamics amidst current market challenges.
  • The firm’s achievement of a 3% revenue growth and margin expansion to 23.6% indicates a robust performance driven by strategic product offerings, particularly the transition to low global warming potential (GWP) R-454B products.
  • This transition seems to have been majorly successful, with approximately 90% of Lennox’s sales now comprising R-454B refrigerant, enhancing product mix and overall profitability.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Isn’t the Market Impatient for the Companies to Implement Management Reforms? and more

By | Daily Briefs, ESG

In today’s briefing:

  • Isn’t the Market Impatient for the Companies to Implement Management Reforms?


Isn’t the Market Impatient for the Companies to Implement Management Reforms?

By Aki Matsumoto

  • More companies are mentioning share buybacks, reducing cross-shareholdings, capital allocation policies, and capital costs. However, the ROE of most companies has not improved significantly.
  • “TSE’s request” is at critical juncture addressing whether it’ll lead to formal improvements such as the introduction of corporate governance code, or whether it’ll enable sustainable growth in corporate value.
  • Looking at recent market trends, investors are increasingly expecting activist investors to directly demand management reforms from companies, in anticipation that it’ll take time to realize results of internal reforms.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars